Cargando…
Aspects of early arthritis. Biological therapy in early arthritis – overtreatment or the way to go?
The availability of newer, and more expensive, therapies for patients with rheumatoid arthritis has changed treatment beyond recognition. Disease remission is the goal for all new patients. Studies have shown that a combination of tumour necrosis factor (TNF)-blocking drugs and methotrexate produces...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2206357/ https://www.ncbi.nlm.nih.gov/pubmed/17540047 http://dx.doi.org/10.1186/ar2177 |